Trump Seeks Supreme Court Intervention to Pause TikTok Ban Ukrainian Drone Strike Ignites Fire at Key Russian Oil Export Terminal Escalating Energy Infrastructure Risks London Stock Exchange Group Reports Income Growth Driven by Tradeweb XP Inc Files Form 6K With SEC as Part of Ongoing Regulatory Disclosure Mercury Achieves 52 Billion Valuation After 200M Funding Round Defying Fintech Downturn Microsoft Appoints Jenny LayFlurrie to Lead Trusted Technology Group Amid AI Speed vs Responsibility Debate RIG Q1 2026 Earnings EPS Misses Estimates Amid Challenging Offshore Drilling Environment DVLT Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed Stock Surges 11 PVL Q1 2023 Earnings Royalty Trust Delivers 013 Per Unit Stock Reacts Positively MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns BIPC Q1 2026 Earnings Significant EPS Miss Amid Market Optimism Cyngn Inc CYN Q1 2026 Earnings Narrowerthanexpected loss props up shares Expro Group Holdings XPRO Holds Steady Near Support Amid Low Volume Session Brighthouse Financial Preferred Stock BHFAO Edges Higher as Support Holds Bluerock Homes Trust BHM Edges Higher Navigating Support and Resistance at 1062 Axogen Inc AXGN Shows Mild Pullback Near Resistance Consolidation Possible Safe Bulkers Inc SB Slides Nearly 4 as Shipping Sector Faces Renewed Pressure Workday Shares Rise on Upgraded Margin Outlook AI Success Claims MNR Q1 2026 Earnings Significant EPS Miss Amid Challenging Conditions Aveanna Healthcare Holdings AVAH Dips 443 Support Levels in Focus After Recent Decline MGPI Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies GDOT Q1 2026 Earnings EPS Surges Past Expectations VSEC Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction ACGLO Q1 2026 Earnings EPS Misses Estimates Amid Mixed Underwriting Conditions BRCB Q1 2026 Earnings EPS Misses Estimates Yet Stock Rises on Operational Stability Clipper Realty Inc Q1 2026 Earnings Positive EPS of 005 Highlights Resilient Operations ADC Therapeutics Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues